Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outpatient elective induction of labour at 39 weeks' gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial.
Nicholson SM, Flood K, Dicker P, Molphy ZE, Smith OT, Oprescu CI, Wall EM, El Nimr SN, Shanahan IM, Kennedy BJ, Daly RV, Gannon G, Looi C, Fernandez E, Malone FD. Nicholson SM, et al. Among authors: malone fd. EClinicalMedicine. 2024 Jul 17;74:102741. doi: 10.1016/j.eclinm.2024.102741. eCollection 2024 Aug. EClinicalMedicine. 2024. PMID: 39114276 Free PMC article.
A randomised open-label trial to assess outpatient induction of labour (HOMEIND) and compare efficacy of Propess vs Dilapan-S® for induction of labour at 39 weeks' gestation in normal risk nulliparous women: study protocol for a randomised controlled trial.
Nicholson SM, Smith O, Hatt S, Molphy Z, Dicker P, Flood K, Malone F. Nicholson SM, et al. Trials. 2023 Feb 23;24(1):135. doi: 10.1186/s13063-023-07174-7. Trials. 2023. PMID: 36814336 Free PMC article.
Logistics for achieving delivery: A secondary analysis of the home induction randomised controlled trial.
Nicholson SM, Flood K, Dicker P, Molphy ZE, Smith OT, Oprescu CI, Wall EM, El Nimr SN, Shanahan IM, Kennedy BJ, Daly RV, Geary MP, Gannon G, Looi C, Cleary BJ, Fernandez E, Malone FD. Nicholson SM, et al. Among authors: malone fd. Eur J Obstet Gynecol Reprod Biol. 2024 Dec 5;305:56-61. doi: 10.1016/j.ejogrb.2024.11.043. Online ahead of print. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 39647250
Born into homelessness: A retrospective observational study.
Leahy C, Murphy CA, Cullen R, Foster P, Malone FD, McCallion N, Cunningham K. Leahy C, et al. Among authors: malone fd. Public Health Pract (Oxf). 2024 Nov 30;8:100559. doi: 10.1016/j.puhip.2024.100559. eCollection 2024 Dec. Public Health Pract (Oxf). 2024. PMID: 39720514 Free PMC article.
Variations in antenatal management and outcomes in haemolytic disease of the fetus and newborn: an international, retrospective, observational cohort study.
de Winter DP, Lopriore E, Thorup E, Petersen OB, Dziegiel MH, Sundberg K, Devlieger R, de Catte L, Lewi L, Debeer A, Houfflin-Debarge V, Ghesquiere L, Garabedian C, Le Duc K, Antolin E, Mendez N, Castleman J, Tse WT, Jouannic JM, Maurice P, Currie J, Mullen E, Geerts L, Rademan K, Khalil A, Poljak B, Prasad S, Tiblad E, Bohlin K, Geipel A, Rath J, Malone F, Mackin D, Yinon Y, Cohen S, Ryan G, Vlachodimitropoulou E, Gloning KP, Verlohren S, Mayer B, Lanna M, Faiola S, Sršen TP, Cerar LK, Snowise S, Sun L, Otaño L, Meller CH, Connors NK, Saxonhouse M, Wolter A, Bedei I, Klaritsch P, Jauch S, da Silva Ribeiro ET, Filho FMP, Martinez-Portilla RJ, Matias A, Abad OA, Roca JP, Grisi ÁGA, Navarro EJJC, van der Bom JG, de Haas M, Verweij EJ; DIONYSUS investigators. de Winter DP, et al. Lancet Haematol. 2024 Dec;11(12):e927-e937. doi: 10.1016/S2352-3026(24)00314-4. Epub 2024 Nov 8. Lancet Haematol. 2024. PMID: 39527958
Variations and Opportunities in Postnatal Management of Hemolytic Disease of the Fetus and Newborn.
de Winter DP, Verweij EJTJ, Debeer A, Devlieger R, Lewi L, Verbeeck S, Maurice P, Jouannic JM, Guillemin MG, Mailloux A, Pessoa Dos Santos MC, Amaral de Moura Sá Pacheco C, Lopes Moreira ME, Martins de Vasconcelos Vaena M, Bohlin K, Tiblad E, Thorup E, Petersen OB, Sanchez-Holgado M, Viejo Llorente A, Poljak B, Khalil A, Le Duc K, Ghesquiere L, Lozar Krivec J, Soltirovska-Šalamon A, Dame C, Blank JD, Hohnecker A, Saxonhouse M, Connors NK, Geipel A, Rath J, Prasad S, van Wyk L, Geerts L, Schuler R, Thon N, Leibovitch L, Cohen S, Canul-Euan AA, Kelly E, Raghuram K, Cavigioli F, Colombo SFG, Elanjikal Z, Brayley J, Pfurtscheller D, Pichler G, Alcázar Grisi ÁG, Chávez Navarro EJJ, Pereira-Nunes J, Soares H, Zhou M, Garcia Borau MJ, Moliner Calderón E, Galletti MF, Mariani GL, Mackin D, Malone F, Lampland A, Tse WT, Castleman J, van der Bom JG, de Haas M, Lopriore E; Worldwide Collaboration for Hemolytic Disease of the Fetus and Newborn (DIONYSUS) Investigators. de Winter DP, et al. JAMA Netw Open. 2025 Jan 2;8(1):e2454330. doi: 10.1001/jamanetworkopen.2024.54330. JAMA Netw Open. 2025. PMID: 39792381 Free PMC article.
Impact of high-risk prenatal screening results for 22q11.2 deletion syndrome on obstetric and neonatal management: Secondary analysis from the SMART study.
Martin K, Norton ME, MacPherson C, Demko Z, Egbert M, Haeri S, Malone F, Wapner RJ, Roman AS, Khalil A, Faro R, Madankumar R, Strong N, Silver R, Vohra N, Hyett J, Kao C, Hakonarson H, Jacobson B, Dar P. Martin K, et al. Prenat Diagn. 2023 Dec;43(13):1574-1580. doi: 10.1002/pd.6483. Epub 2023 Dec 8. Prenat Diagn. 2023. PMID: 38066724
Performance of prenatal cfDNA screening for sex chromosomes.
Martin K, Dar P, MacPherson C, Egbert M, Demko Z, Parmar S, Hashimoto K, Haeri S, Malone F, Wapner RJ, Roman AS, Khalil A, Faro R, Madankumar R, Strong N, Silver RM, Vohra N, Hyett J, Rabinowitz M, Kao C, Hakonarson H, Jacobsson B, Norton ME. Martin K, et al. Genet Med. 2023 Aug;25(8):100879. doi: 10.1016/j.gim.2023.100879. Epub 2023 May 5. Genet Med. 2023. PMID: 37154148 Free article.
248 results